Amgen Inc. Available-for-sale Securities, Gross Unrealized Gain
Amgen Inc. (AMGN) reported Available-for-sale Securities, Gross Unrealized Gain of $175.00 million for the 3-month period ending 2011-03-31, per its 10-Q filed 2011-05-10.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2011-05-10
- Amgen Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2011-03-31 was $175.00M.
- Amgen Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2010-12-31 was -$147.00M.
- Amgen Inc. available-for-sale securities, gross unrealized gain for the quarter ending 2010-09-30 was $118.00M.
- Amgen Inc. available-for-sale securities, gross unrealized gain for fiscal 2009 was $174.00M.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month |
|---|---|---|---|---|
| 2011-03-31 | $175.00M 10-Q · filed 2011-05-10 | $28.00M derived: sum of 2 quarters · filed 2011-05-10 | $146.00M derived: sum of 3 quarters · filed 2011-05-10 | |
| 2010-12-31 | -$147.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2011-05-10 | -$29.00M derived: sum of 2 quarters · filed 2011-05-10 | $256.00M 10-Q · filed 2011-05-10 | |
| 2010-09-30 | $118.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $403.00M 10-Q · filed 2010-11-08 | ||
| 2010-06-30 | $285.00M 10-Q · filed 2010-08-09 | |||
| 2009-12-31 | $174.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |